DRKS00000531招募中未知
Polypharmacy as a result of multiple chronic conditions of older people: rational therapy with the new FORTA classification?
Institut für klinische Pharmakologie MannheimUniversität Heidelberg0 个研究点目标入组 400 人开始时间: 2010年9月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 65 Years 至 100 Years（—）
- 性别
- All
入选标准
- •informed consent given,
- •stable clinical condition,
- •no palliative condition
排除标准
- •missing informed consent,
- •palliative clinical condition,
- •unstable clinical condition,
- •need of intensive care unit (ICU) treatment
研究者
相似试验
已完成
不适用
PRIMA-eDS: Polypharmacy in chronic diseases: Reduction of Inappropriate Medication and Adverse drug events in elderly populations by electronic Decision SupportISRCTN10137559Witten/Herdecke University (Universität Witten/Herdecke)3,904
已完成
不适用
Living With Multimorbidity: CO-ORDINATE ProgramMultimorbidityQuality of LifeSymptom ManagementNCT05985044Johns Hopkins University27
尚未招募
不适用
Polypharmacy of antipsychotics in SchizophreniaCTRI/2021/04/033286Paul Mathew
已完成
不适用
Medication Regimen Complexity and Glycemic Control in Patients With DiabetesDiabetes MellitusNCT03324971Kasr El Aini Hospital78
尚未招募
不适用
Multimorbidity, polypharmacy, and glucose-lowering drugs, and their effects in patients with type 2 diabetes: A longitudinal study of real-world dataType 2 diabetes mellitusJPRN-UMIN000046736Teijin Pharma Limited50,000